+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Direct healthcare cost of obesity in brazil: an application of the cost-of-illness method from the perspective of the public health system in 2011



Direct healthcare cost of obesity in brazil: an application of the cost-of-illness method from the perspective of the public health system in 2011



Plos One 10(4): E0121160



Obesity is a global public health problem and a risk factor for several diseases that financially impact healthcare systems. To estimate the direct costs attributable to obesity (body mass index {BMI} ≥ 30 kg/m2) and morbid obesity (BMI ≥ 40 kg/m2) in adults aged ≥ 20 incurred by the Brazilian public health system in 2011. Public hospitals and outpatient care. A cost-of-illness method was adopted using a top-down approach based on prevalence. The proportion of the cost of each obesity-associated comorbidity was calculated and obesity prevalence was used to calculate attributable risk. Direct healthcare cost data (inpatient care, bariatric surgery, outpatient care, medications and diagnostic procedures) were extracted from the Ministry of Health information systems, available on the web. Direct costs attributable to obesity totaled US$ 269.6 million (1.86% of all expenditures on medium- and high-complexity health care). The cost of morbid obesity accounted for 23.8% (US$ 64.2 million) of all obesity-related costs despite being 18 times less prevalent than obesity. Bariatric surgery costs in Brazil totaled US$ 17.4 million in 2011. The cost of morbid obesity in women was five times higher than it was in men. The cost of morbid obesity was found to be proportionally higher than the cost of obesity. If the current epidemic were not reversed, the prevalence of obesity in Brazil will increase gradually in the coming years, as well as its costs, having serious implications for the financial sustainability of the Brazilian public health system.

(PDF emailed within 0-6 h: $19.90)

Accession: 057630333

Download citation: RISBibTeXText

PMID: 25830909

DOI: 10.1371/journal.pone.0121160


Related references

Cost analysis of18F-FDG PET-CT from the perspective of the Brazilian Unified National Health System as healthcare provider: a study in a public healthcare center in Rio de Janeiro, Brazil. Cadernos de Saude Publica 30(2): 379-392, 2014

Systematic Review and Cost-Effectiveness Analysis of Drug Used in Obesity Treatment in Brazil, Under Health System Perspective. Value in Health 18(7): A842, 2015

Cost-effectiveness analysis of pharmaceutical care for hypertensive patients from the perspective of the public health system in Brazil. Plos One 13(3): E0193567, 2018

An economic perspective on childhood obesity: recent findings on cost of illness and cost effectiveness of interventions. Nutrition 28(9): 829-839, 2012

Incremental cost-effectiveness of percutaneous versus surgical closure of atrial septal defects in children under a public health system perspective in Brazil. Expert Review of Cardiovascular Therapy 12(11): 1369-1378, 2015

Burden of migraine in Brazil: Estimate of cost of migraine to the public health system and an analytical study of the cost-effectiveness of a stratified model of care. Headache 43(7): 742-754, July-August, 2003

Economic analysis and public health: Why do we need economic evaluation applied to diabetes? What methods must we choose: Cost-effectiveness, cost-utility, cost-benefit? Are such studies useful in terms of public health?. Diabete & Metabolisme 19(5 SUPPL ): 473-476, 1993

Economic analysis and public health. Why does one need economic evaluation applied to diabetes? What methods does one choose: cost effectiveness, cost utility, cost benefit? Are such studies useful in terms of public health?. Diabete and Metabolisme 19(5 Suppl): 473-476, 1993

Can hydrophilic coated catheters be beneficial for the public healthcare system in Brazil? - A cost-effectiveness analysis in patients with spinal cord injuries. International Braz J Urol 44(1): 121-131, 2017

Illness Mapping: a time and cost effective method to estimate healthcare data needed to establish community-based health insurance. Bmc Medical Research Methodology 12: 153, 2013

The cost of violence for the public health system in Brazil: available data and possibilities for estimation. Cadernos de Saude Publica 25(1): 29-36, 2009

Healthcare costs of intellectual disability in the Netherlands: A cost-of-illness perspective. Journal of Intellectual Disability Research 46(2): 168-178, 2002

The burden of unintended pregnancies in Brazil: a social and public health system cost analysis. International Journal of Women's Health 6: 663-670, 2014

Direct healthcare costs and cost-effectiveness of acute coronary syndrome secondary prevention with ticagrelor compared to clopidogrel: economic evaluation from the public payer's perspective in Poland based on the PLATO trial results. Kardiologia Polska 72(9): 823-830, 2016

Canadian Potential Healthcare and Societal Cost Savings from Consumption of Pulses: A Cost-Of-Illness Analysis. Nutrients 9(7), 2018